Compounds > oxacillin
Page last updated: 2024-08-17

oxacillin and ppi-0903

oxacillin has been researched along with ppi-0903 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Biek, D; Ge, Y; Sahm, DF; Talbot, GH1
Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS1
Murray, KP; Newton, KL; Nonejuie, P; Pogliano, J; Rybak, MJ; Sakoulas, G; Vidaillac, C; Werth, BJ1
Dien Bard, J; Gold, HS; Hindler, JA; Limbago, B1
Balada-Llasat, JM; Bauer, KA; Bremmer, DN; Goff, DA1
Abad, L; Benito, Y; Bes, M; Camus, C; Chidiac, C; Dupieux, C; Ferry, T; Laurent, F; Lustig, S; Trouillet-Assant, S; Valour, F1
Drewry, DH; Ferrer, CA; Rose, WE; Sauer, JD; Schaenzer, AJ; Striker, R; Wlodarchak, N; Zuercher, WJ1
Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Streit, JM1

Other Studies

8 other study(ies) available for oxacillin and ppi-0903

ArticleYear
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States

2008
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin

2011
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Anti-Bacterial Agents; Boron Compounds; Ceftaroline; Cell Wall; Cephalosporins; Drug Combinations; Drug Synergism; Fluorescent Dyes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Vancomycin Resistance

2013
Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillins; Staphylococcal Infections; Staphylococcus; United States; United States Food and Drug Administration

2014
Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses.
    Diagnostic microbiology and infectious disease, 2017, Volume: 88, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftaroline; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Disk Diffusion Antimicrobial Tests; Humans; Oxacillin; Staphylococcus aureus

2017
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA.
    The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12

    Topics: Anti-Bacterial Agents; Ceftaroline; Cell Line; Cephalosporins; Colony Count, Microbial; Daptomycin; Drug Synergism; Humans; Methicillin Resistance; Microbial Viability; Osteoblasts; Oxacillin; Staphylococcus aureus

2017
GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureus.
    ACS infectious diseases, 2018, 10-12, Volume: 4, Issue:10

    Topics: Adjuvants, Pharmaceutic; Autoradiography; beta-Lactam Resistance; Ceftaroline; Cephalosporins; Drug Synergism; fms-Like Tyrosine Kinase 3; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Protein Kinase Inhibitors; Pyridazines; Small Molecule Libraries; Staphylococcal Infections

2018
Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014-2018): therapeutic options for multidrug-resistant bacteria.
    Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:2

    Topics: Adolescent; Anti-Infective Agents; Azabicyclo Compounds; Bacteria; Bacterial Proteins; beta-Lactamases; Candida; Ceftaroline; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Oxacillin; Sepsis; United States

2020